CHANGE IN RATINGS
downgraded at Credit Suisse to Underperform from Neutral. Limited flexibility stemming from de-leveraging results, negative outlook for same store sales, and negative cash flows for multiple stores has led to the decline in ratings. Maintained price target of $3.
downgraded at Credit Suisse to Underperform from Neutral. Market share challenges, several structural negatives, and tightening consumer credit has led to the reduction of ratings. Maintained price target of $8.
upgraded at Goldman Sachs to Buy from Neutral based on leverage to domestic construction. Note that Build America Bonds, stimulus funding and passage of the California state budget represent positive catalysts. Price target at $41.
upgraded from Underperform to Buy at Merrill Lynch/Bank of America. Estimates appear conservative, and the company is executing ahead of plan. $35 price target.
downgraded at Credit Suisse to Neutral from Outperform. Due to its recent surge in share price, they believe the stock is fully valued and remains open to several structural negatives in the mall anchor industry. Maintained price target of $22.
downgraded at UBS to neutral from buy and price target decreased to $34 from $35. While PEG is in a strong financial position and visible growth from its lower risk-utility business, these merits are sufficiently captured in current valuation. UBS sees greater opportunities from compelling names like ETR, PPL and SRE in the group.
downgraded at Credit Suisse to Underperform from Neutral. Citing underproductive store bases and several full line stores having negative cash flows. Maintained price target of $2.
upgraded at Goldman Sachs to Buy from Neutral based on renegotiation of royalty agreement with Samsung. Expect positive revaluation of intellectual property, along with improving NAND fundamentals. Price target raised to $22 from $16.
downgraded at Goldman Sachs to Neutral from Buy. Recent strong rally (up 50% since Feb 19) has left shares with a less attractive risk/reward. Price target raised to $53 from $51.
STOCK COMMENTS / EPS CHANGES
estimates raised at UBS through 2011. Company is lowering costs and inventory levels are improving. Neutral rating and $16 price target.
target raised at Credit Suisse to $179 from $175. Strong earnings results and the best operating profit growth for this company in several years has indicated a strong outlook ahead. Maintained Outperform rating.
( BGP) target raised at Credit Suisse to $3.50 from 50 cents. Reducing costs, conserving capital and putting forth strong Q1 results has indicated they are back on the right track towards profitability. Maintained a Neutral rating.
numbers cut at Barclays through 2010. Price discounting across the industry could hurt near-term results. Overweight rating and new $21 price target.
estimates, target raised at UBS to $10. Estimates also increased, to reflect better margins and a clean inventory level. Neutral rating.
numbers boosted at Barclays through 2010. Stronger near-term orders should lead to margin improvement. Overweight rating and new $11 price target.
estimates, target increased at Barclays to $48. Estimates also boosted, to reflect strong sales momentum. Equal-weight rating.
estimates, target increased at Barclays. Shares now seen reaching $7. Estimates raised to reflect the new liquidity cushion. Equal-weight rating.
numbers raised at Merrill/BofA to $12. Company should likely exceed April quarter guidance. Neutral rating and new $12 price target.
target increased at Merrill/Bank of America to $45. Company still faces top-line risks and could be hurt by international investments, but a lower tax rate boosted earnings. Underperform rating.
estimates, target raised at UBS through 2011 because of cost cutting. Sell rating and new $47 price target.
This article was written by a staff member of TheStreet.com.